Reduce Patient Burden and Improve Outcomes with Real World Data

Tyler Pugsley, Medable’s Vice President of Life Sciences has almost a decade of experience partnering with pharmaceutical sponsors and CROs to advise and develop innovative clinical trial technologies. An evangelist in the Medable mission of bringing effective therapies to patients faster, Tyler consistently pushes the boundaries of what is considered possible in clinical trials.

Ardy Arianpour is CEO & Co-Founder of Seqster, the leading patient-centric SaaS healthcare technology company that enables organizations to drive efficient healthcare via comprehensive medical records (EHR), individual genomic profiles (DNA), and personal health device data. For the first time, users create their own matched, longitudinal health data profile across all of their US-based healthcare data sources through person-centric interoperability. Ardy is a visionary health tech executive and serial entrepreneur in biotech and digital health. Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion. As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country. Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management. He was a Medical, Marketing, and Media’s (MM&M) Top 40 Healthcare Transformer and San Diego Business Journal 40 under 40.

Devin leads strategy and business development for clinical trial solutions at Datavant, where he's helped to launch trial tokenization, enabling sponsors to link real-world data with clinical trials. Devin previously led real-world evidence solutions for the oncology data analytics company Syapse, where he worked with life sciences partners to build synthetic control arms and innovative outcomes research data products.

Christopher Boone, PhD has a career-long history as a dynamic, innovative thought leader and a public voice on the power of real-world evidence, health informatics, and big data analytics and its ability to radically transform the global health care system into a learning health system. Chris currently serves as the Vice President, Global Head of Health Economics and Outcomes Research at Abbvie. He is also an adjunct assistant professor of health administration at the New York University's Robert F. Wagner Graduate School of Public Service, an active board member of several influential organizations, and a co-founder of a few start-up companies. Prior to AbbVie, he served in two different roles at Pfizer: (1) the Vice President and Head of Global Medical Epidemiology and Big Data Analysis at Pfizer, and (2) the Vice President and Global Head of Real-World Data and Analytics. Chris has been recognized as a 2020 Global Top 100 Innovator in Data & Analytics, a 2019 Top 100 Innovator in Data & Analytics, a 2018 Emerging Pharma Leader by Pharmaceutical Executive, and a 2017 Top 40 Under 40 Leader in Minority Health by the National Minority Quality Forum (NMQF). Boone holds, or has held, appointments to some of the most influential national committees focused on health data and patient centricity, including the Board of Directors for Global Medical Response, the Board of Directors for the Stewards of Change Institute, the Executive Board of Directors for the Patient Advocate Foundation, the Executive Board of Directors for the National Patient Advocate Foundation, the U.S. Department of Health and Human Services (HHS) Federal Health IT Policy Committee, the HHS National Committee on Vital and Health Statistics (NCVHS) Working Group on HHS Data Access and Use, the inaugural advisory group for American Society of Clinical Oncologists’ (ASCO) CancerLinQ, the Board of Directors for SHARE for Cures, the Robert Wood Johnson Foundation’s Data Across Sectors for Health (DASH) Initiative, and the Interoperability Committee for the National Quality Forum. Chris earned a B.S. from the University of Tulsa, a M.H.A. from the University of Texas at Arlington, a Ph.D. from the University of Texas at Dallas, and two executive certificates from the Harvard Kennedy School. He is a Fellow of the American College of Health Executives and a Fellow of the Healthcare Information Management & Systems Society.